Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Obstructive Sleep Apnea and Insulin Resistance
NCT02192684Completed
- Sponsor
- Stanford University
- Start
- Sep 2010
- Primary completion
- Jul 2014
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in obstructive sleep apnea (OSA) and insulin resistance (IR) comparing Pioglitazone with Placebo (2 arms). Primary endpoint: Change in Apnea-hypopnea Index at 8 weeks. Started Sep 2010; status: completed.
02
Drugs
pioglitazone
03
Conditions
obstructive sleep apnea (OSA)insulin resistance (IR)
Beyond the preview
Go deeper on NCT02192684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02192684.